Silk Road Medical, Inc. (NASDAQ:SILK) has scheduled a conference call for 10th November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website silkroadmed.com
Earnings Expectation
Silk Road Medical, Inc. is reporting third quarter financial results on Tuesday 10th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, SILK is expected to report 3Q20 loss of $ 0.28 per share from revenue of $ 19.59 million.
For the full year, analysts anticipate top line of $ 76.79 million, while looking forward to loss of $ 1.12 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 92.00 million ~ $ 95.00 million
Click Here For More Historical Outlooks Of Silk Road Medical, Inc.
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices.
